A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia

Kevin T. McVary, Claus Roehrborn, Emmanuel Chartier-Kastler, Mitchell Efros, Denise Bugarin, Ru Chen, Anand Patel, Cornelia Haag-Molkenteller

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint Dive into the research topics of 'A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences